KLYG Stock Overview
A medical device manufacturing company, engages in the production of custom prosthetics cranial implants utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
Kelyniam Global, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.32 |
| 52 Week High | US$0.39 |
| 52 Week Low | US$0.042 |
| Beta | -1.22 |
| 1 Month Change | 52.33% |
| 3 Month Change | 59.95% |
| 1 Year Change | 433.17% |
| 3 Year Change | 159.03% |
| 5 Year Change | 307.62% |
| Change since IPO | 16.33% |
Recent News & Updates
Recent updates
Shareholder Returns
| KLYG | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -0.4% | 0.7% | 1.5% |
| 1Y | 433.2% | 13.0% | 22.4% |
Return vs Industry: KLYG exceeded the US Medical Equipment industry which returned 13% over the past year.
Return vs Market: KLYG exceeded the US Market which returned 22.4% over the past year.
Price Volatility
| KLYG volatility | |
|---|---|
| KLYG Average Weekly Movement | 25.2% |
| Medical Equipment Industry Average Movement | 7.9% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 18.0% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: KLYG's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: KLYG's weekly volatility (25%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | n/a | Ross Bjella | www.kelyniam.com |
Kelyniam Global, Inc., a medical device manufacturing company, engages in the production of custom prosthetics cranial implants utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers in the United States. The company is also involved in the development, manufacture, and distribution of custom cranial and maxilla-facial implant for patients requiring the reconstruction of cranial and facial structures. It serves surgeons, health systems, and payors.
Kelyniam Global, Inc. Fundamentals Summary
| KLYG fundamental statistics | |
|---|---|
| Market cap | US$15.90m |
| Earnings (TTM) | -US$218.47k |
| Revenue (TTM) | US$2.67m |
6.0x
P/S Ratio-72.8x
P/E RatioIs KLYG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KLYG income statement (TTM) | |
|---|---|
| Revenue | US$2.67m |
| Cost of Revenue | US$636.28k |
| Gross Profit | US$2.04m |
| Other Expenses | US$2.25m |
| Earnings | -US$218.47k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0044 |
| Gross Margin | 76.19% |
| Net Profit Margin | -8.18% |
| Debt/Equity Ratio | 80.1% |
How did KLYG perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/16 12:28 |
| End of Day Share Price | 2025/02/14 00:00 |
| Earnings | 2023/12/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Kelyniam Global, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.